GCC regulatory requirements for Saudi Arabia and UAE MCQs With Answer

GCC regulatory requirements for Saudi Arabia and UAE MCQs With Answer

This short quiz set is designed for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics. It focuses on practical regulatory requirements and procedures specific to Saudi Arabia and the United Arab Emirates, highlighting national authorities, dossier requirements, labelling, pharmacovigilance, GMP/GDP, clinical trial approvals and importation controls. Questions emphasize documents commonly requested (CPP, GMP certificates, stability data), local representation and language rules, plus special considerations for controlled substances and biologics. These MCQs aim to deepen conceptual understanding and prepare students for regulatory roles involving drug registration and post‑approval compliance in the GCC pharmaceutical environment.

Q1. Which authority is the primary regulator for pharmaceuticals in Saudi Arabia?

• Ministry of Health (MOH)
• Saudi Food and Drug Authority (SFDA)
• Dubai Health Authority (DHA)
• Department of Health Abu Dhabi (DOH)

Correct Answer: Saudi Food and Drug Authority (SFDA)

Q2. Which federal body is responsible for drug regulation at the UAE national level?

• Dubai Health Authority (DHA)
• Ministry of Health and Prevention (MOHAP)
• Department of Health Abu Dhabi (DOH)
• Emirates Authority for Standards

Correct Answer: Ministry of Health and Prevention (MOHAP)

Q3. Which document, issued by the exporting country’s regulator, is commonly required to support a drug marketing application in both Saudi Arabia and the UAE?

• Good Manufacturing Practice (GMP) certificate
• Certificate of Pharmaceutical Product (CPP)
• Certificate of Analysis (CoA)
• Certificate of Free Sale

Correct Answer: Certificate of Pharmaceutical Product (CPP)

Q4. Which of the following is typically mandatory from the manufacturer when applying for marketing authorization in the GCC?

• Local batch recall plan only
• Good Manufacturing Practice (GMP) certificate
• Only product brochures
• Sales forecasts for five years

Correct Answer: Good Manufacturing Practice (GMP) certificate

Q5. What are the common labelling language requirements for medicines marketed in Saudi Arabia and the UAE?

• English only
• Arabic only
• Both Arabic and English
• Arabic and French

Correct Answer: Both Arabic and English

Q6. Who holds primary responsibility for pharmacovigilance and adverse event reporting for a marketed product in Saudi Arabia and the UAE?

• Local distributor with no oversight from the manufacturer
• Marketing Authorization Holder (MAH) or local responsible entity
• Only the national regulatory authority
• Import customs authority

Correct Answer: Marketing Authorization Holder (MAH) or local responsible entity

Q7. Which dossier format is generally expected by GCC regulators for medicinal product submissions?

• eCTD or CTD (Common Technical Document) format
• Paper leaflet only
• International Organization for Standardization (ISO) format
• Non-structured PDF summaries only

Correct Answer: eCTD or CTD (Common Technical Document) format

Q8. For legal representation in Saudi Arabia and the UAE, what is required from foreign applicants seeking marketing authorization?

• No representation; direct submission only
• Local authorised representative or local agent
• Only a distributor contract with a pharmacy is sufficient
• An embassy attestation instead of a local agent

Correct Answer: Local authorised representative or local agent

Q9. For generic drug registration in Saudi Arabia and the UAE, what type of study is commonly required to demonstrate equivalence to the reference product?

• Toxicology studies only
• Bioequivalence studies where applicable
• Only marketing data from other markets
• Animal efficacy studies

Correct Answer: Bioequivalence studies where applicable

Q10. Importation of controlled narcotic or psychotropic medicines into Saudi Arabia and the UAE typically requires:

• No special documentation beyond routine customs forms
• Special import permit and adherence to narcotics control procedures
• Only a purchase invoice from the manufacturer
• A letter from the local pharmacy chain

Correct Answer: Special import permit and adherence to narcotics control procedures

Q11. Stability data submitted for GCC registration should follow which guideline and climatic considerations?

• No stability data required for registration
• ICH Q1A stability guideline with conditions appropriate for climatic zone IV (hot conditions)
• Only long-term data at refrigerated conditions
• WHO guideline ignoring climatic zones

Correct Answer: ICH Q1A stability guideline with conditions appropriate for climatic zone IV (hot conditions)

Q12. Which document certifies the quality of a specific product batch released by the manufacturer?

• Certificate of Analysis (CoA)
• Marketing Authorization Certificate
• Certificate of Pharmaceutical Product (CPP)
• Good Distribution Practice (GDP) certificate

Correct Answer: Certificate of Analysis (CoA)

Q13. If a registered product manufacturer intends to change a critical manufacturing site or process, what is the regulatory expectation in Saudi Arabia and the UAE?

• Proceed immediately and notify the regulator after first sale
• Submit a variation/variation application and obtain approval before implementation where required
• No action needed for any changes
• Only inform the local distributor informally

Correct Answer: Submit a variation/variation application and obtain approval before implementation where required

Q14. What is the primary purpose of a Certificate of Pharmaceutical Product (CPP) in GCC registrations?

• To confirm export taxes have been paid
• To confirm the product is authorized for sale in the issuing country and provide regulatory history
• To serve as a marketing leaflet for patients
• To replace GMP certification

Correct Answer: To confirm the product is authorized for sale in the issuing country and provide regulatory history

Q15. Which regulatory authority is responsible for issuing marketing approvals for pharmaceuticals specifically in Dubai?

• Ministry of Health and Prevention (MOHAP)
• Department of Health Abu Dhabi (DOH)
• Dubai Health Authority (DHA)
• Saudi Food and Drug Authority (SFDA)

Correct Answer: Dubai Health Authority (DHA)

Q16. Approval to conduct clinical trials in Saudi Arabia requires which of the following?

• Only approval from the local hospital director
• Ethics committee/Institutional Review Board (IRB) approval and SFDA clinical trial authorization
• Only a sponsor declaration
• Marketing authorization first, then trials

Correct Answer: Ethics committee/Institutional Review Board (IRB) approval and SFDA clinical trial authorization

Q17. Before a pharmaceutical consignment can be imported into Saudi Arabia or the UAE for commercial distribution, what is generally required?

• Only a commercial invoice and packing list
• Valid marketing authorization and an import permit or clearance
• Only an endorsement letter from the embassy
• No prior permission; goods clear on arrival

Correct Answer: Valid marketing authorization and an import permit or clearance

Q18. For biologic products, GCC regulators expect additional submission data compared with small molecules. Which of these is typically requested?

• Only photos of the product vial
• Comprehensive characterization, comparability data, stability and cold-chain assurance
• No additional data beyond standard CTD modules
• Only pricing justification

Correct Answer: Comprehensive characterization, comparability data, stability and cold-chain assurance

Q19. During marketing authorization review in Saudi Arabia and the UAE, regulatory authorities commonly request physical product samples. What is the role of submitted samples?

• Samples are used solely for marketing photos
• Samples may be tested by regulatory laboratories to confirm quality and label claims
• Samples replace the need for a Certificate of Analysis
• Samples are not accepted at any time

Correct Answer: Samples may be tested by regulatory laboratories to confirm quality and label claims

Q20. What is the general regulatory position in Saudi Arabia and the UAE regarding direct-to-consumer advertising of prescription-only medicines?

• Direct-to-consumer advertising of prescription medicines is generally prohibited
• All prescription medicines may be freely advertised to the public
• Only televised ads are allowed without restrictions
• Advertising is allowed only in English

Correct Answer: Direct-to-consumer advertising of prescription medicines is generally prohibited

Download